[HTML][HTML] Clinical translation and first in-human use of [44Sc] Sc-PSMA-617 for PET imaging of metastasized castrate-resistant prostate cancer
E Eppard, A de la Fuente, M Benešová, A Khawar… - Theranostics, 2017 - ncbi.nlm.nih.gov
Background: Various trivalent radiometals are well suited for labeling of DOTA-conjugated
variants of Glu-ureido-based prostate-specific membrane antigen (PSMA) inhibitors. The …
variants of Glu-ureido-based prostate-specific membrane antigen (PSMA) inhibitors. The …
Clinical Translation and First In-Human Use of [44Sc]Sc-PSMA-617 for PET Imaging of Metastasized Castrate-Resistant Prostate Cancer.
E Eppard, A de la Fuente, M Benešová, A Khawar… - Theranostics, 2017 - europepmc.org
Background Various trivalent radiometals are well suited for labeling of DOTA-conjugated
variants of Glu-ureido-based prostate-specific membrane antigen (PSMA) inhibitors. The …
variants of Glu-ureido-based prostate-specific membrane antigen (PSMA) inhibitors. The …
Clinical Translation and First In-Human Use of [44Sc] Sc-PSMA-617 for PET Imaging of Metastasized Castrate-Resistant Prostate Cancer
E Eppard, A de la Fuente, M Benešová… - …, 2017 - pubmed.ncbi.nlm.nih.gov
Background Various trivalent radiometals are well suited for labeling of DOTA-conjugated
variants of Glu-ureido-based prostate-specific membrane antigen (PSMA) inhibitors. The …
variants of Glu-ureido-based prostate-specific membrane antigen (PSMA) inhibitors. The …
[引用][C] Clinical Translation and First In-Human Use of [44Sc]Sc-PSMA-617 for PET Imaging of Metastasized Castrate-Resistant Prostate Cancer
E Eppard, A de la Fuente, M Benešová, A Khawar… - Theranostics, 2017 - cir.nii.ac.jp
Clinical Translation and First In-Human Use of [<sup>44</sup>Sc]Sc-PSMA-617 for PET
Imaging of Metastasized Castrate-Resistant Prostate Cancer | CiNii Research CiNii 国立 …
Imaging of Metastasized Castrate-Resistant Prostate Cancer | CiNii Research CiNii 国立 …
[PDF][PDF] Clinical Translation and First In-Human Use of [44Sc] Sc-PSMA-617 for PET Imaging of Metastasized Castrate-Resistant Prostate Cancer
E Eppard, A de la Fuente, M Benešová, A Khawar… - pdfs.semanticscholar.org
Background: Various trivalent radiometals are well suited for labeling of DOTA-conjugated
variants of Glu-ureido-based prostate-specific membrane antigen (PSMA) inhibitors. The …
variants of Glu-ureido-based prostate-specific membrane antigen (PSMA) inhibitors. The …
[PDF][PDF] Clinical Translation and First In-Human Use of [44Sc] Sc-PSMA-617 for PET Imaging of Metastasized Castrate-Resistant Prostate Cancer
E Eppard, A de la Fuente, M Benešová, A Khawar… - researchgate.net
Background: Various trivalent radiometals are well suited for labeling of DOTA-conjugated
variants of Glu-ureido-based prostate-specific membrane antigen (PSMA) inhibitors. The …
variants of Glu-ureido-based prostate-specific membrane antigen (PSMA) inhibitors. The …